Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
they manufacture the test, they don't create it. Big companies do this all themselves. Odx isn't going to ever get bought out. People need to see this is a failing company, remove the rose tinted glasses
Investors will want a better discount on placing. 2p.
Because the company is run awfully.
amazing that ODX is now in a far worse position than they were pre-covid.
I have explained why I am still here already. Nice deflection though. Don't worry, I won't be on the board for much longer- seems futile now. I just hope people do their own, thorough DD and not listen to people on BBs or social media. And definitely don't listen to people like Manifesto claiming there were secret meetings last weeks, EUA is still going to happen, scientists will back the trial to enable approval because of the impact of steroids and chemo is SOC in cancer.
Manifesto, you are in way over your head here. "standard of care for cancer is chemo". lol
The fact of the matter is, sng need to do another larger phase 3 trial looking at either a similar patient group stratified for steroid use, or vs dex directly. Our current data shows there is not a stat sig difference betwen patients when steroids are being used- so not so great when you are comparing to soc. Yes there might be patients where steroids are ci'd where interferon comes in. Clutching at straws
Manifesto, what on earth are you on about? You can't fail a trial and then a few other scientistics/clinicians come out and say "actually it would work really well if...." and then get an approval lol
Axe, I have been here for 2 years, you don't need to update me on what is happening with the activ trial lol. My point is, like you have also now stated, phase 3 involving sng has NOT STARTED. Therefore any results won't be due for at least 12 months or so. That is my point.
Doc, you're right I have sold. I am here because I knew how this board was going to react. New posters (and some old) barking on about activ-2, the positives, how we can still get EUA and a lot of people who don't neccessarily understand it all being driven to buying on false pretences.
It was definitely not the number 1 trial. You are putting all your eggs in the basket of a trial that HAS NOT YET STARTED and will not read out for at least 12 MONTHS. This is not difficult to understand. Very tired of all the ramping here.
Im baffled as to how you find this undervalued. No product will be coming to market for at least 12-18 months. Another large trial will need to be funded as well as activ-2 phase 3 starting and finishing. THis share was always £10 or 10p (slight exaggeration both ways).